13F

Stock

Recursion Pharmaceuticals In

Ticker not mapped · held by 5 managers

Reported value

$21.3M

Holders

5

+0 new · −2 exited

Holders’ est. mark

−$879.4K

Price effect on 3 books still in the name

Largest holder

$18M

NORGES BANK

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
NORGES BANK3.41M$18MHeld
BARCLAYS PLC591K$3.13M−$868.8KCut−$1.15M
Sanctuary Advisors, LLC10.5K$55.5KHeld
Leonteq Securities AG7.43K$39.2K−$7.32KAdded$5.86K
CHESAPEAKE ASSET MANAGEMENT LLC2.27K$12K−$3.33KCut−$11.9K

Who left

Positions as of Q1 2025. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.